Cancer and Leukemia Group B

描述（由申请人提供）：本Ul 0申请旨在支持通过维克森林大学医学院（WFUSM）及其附属成员开展的CALGB合作组临床试验。WFUSM连续45年获得CALGB U10资助（CA 03927），作为数据管理基础设施的关键支持，与我们的附属成员进行必要的行政互动，以及支持对CALGB的科学和行政贡献。除了支持主要成员，这U10赠款支持在我们目前的两个附属成员，东卡罗莱纳大学，格林维尔，北卡罗来纳州和索尔兹伯里，索尔兹伯里，北卡罗来纳州卡罗莱纳肿瘤协会的活动的监督。这项赠款申请的具体目的是： * 增加我们对疾病和模式委员会活动的科学贡献 * 通过在维克森林大学综合癌症中心开发试点数据（可开发为CALGB方案），提高临床研究调查者的参与度 * 扩大维克森林大学综合癌症中心的附属网络，以便通过访问CALGB癌症临床试验为癌症患者提供更好的护理 * 提供一个临床试验机制，使少数群体能够参与临床试验;提高他们参与临床试验研究的比例;制定具体战略，解决临床研究中招募和保留少数群体的区域障碍 * 继续我们作为一个受资助的预防成员中心的参与

DESCRIPTION (provided by applicant): This Ul0 application is in support of the CALGB Cooperative Group Clinical Trials conducted through the Wake Forest University School of Medicine (WFUSM) and its affiliate Members. WFUSM has been continuously awarded a CALGB U10 Grant for 45 years (CA03927) as the key support of the infrastructure for data management, the required administrative interactions with our Affiliate Members, and for the support of scientific and administrative contributions to CALGB. In addition to support for the Main Member, this U10 Grant supports the oversight of activity at our two current Affiliate Members, East Carolina University, Greenville, North Carolina and Carolina Oncology Associates of Salisbury, Salisbury, North Carolina. The specific aims of this grant application are: * To increase our scientific contributions to Disease and Modality Committee activities * To enhance the participation of our clinical research investigators through the development of pilot data at the Comprehensive Cancer Center of Wake Forest University that can be developed into CALGB protocols * To expand the Affiliate Network of the Comprehensive Cancer Center of Wake Forest University in order to provide improved care of the cancer patient through access to CALGB Cancer Clinical Trials * To provide a clinical trials mechanism by which minority populations can accrue to clinical trails; to improve their proportional participation in clinical trials research; and to develop specific strategies to address regional barriers to minority recruitment and retention in clinical research studies * To continue our participation as a funded Prevention Member Center